Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Search stocks
Sarthak Metals Ltd

| Transcript of Earnings Call

NEUTRAL SENTIMENT

Report Source

⬤13th Nov 25

Summary : Sarthak Metals is diversifying beyond its core steel-related business into high-growth welding and biotechnology segments, aiming for resilience despite current steel sector headwinds.

Management Perspective positive : Our internal transformation is providing us with the stability and the optimism we had envisioned. We are very confident of achieving that sales figure. We are very optimistic. We're seeing a positive silver lining here. The journey I had looks bumpy but very exciting. Its looking like a huge opportunity.

Concall Report Analysis & Insights

Business Overview

  1. Sarthak Metals operates in cored wires and aluminium wires.
  2. The company has diversified into welding consumables, a high-growth segment.
  3. A strategic foray into biotechnology is actively gaining traction.
  4. The business model is now diversified across three strong pillars.
  5. The company aims to evolve from a single-sector player.

Future Growth Prospects

  1. Welding division shows strong momentum with over 100 tons monthly volumes.
  2. BIS and RDSO approvals open significant new avenues for welding products.
  3. Biotechnology initiative is in advanced discussions with ethanol distilleries.
  4. Massive CapEx in the ethanol industry creates a huge market opportunity.
  5. Government's aggressive fuel blending program supports biofuel growth.

Management Insights

  1. The company is undergoing a transformation to build a resilient, future-ready business.
  2. Strategic decision to temporarily step back from aluminium flipping coil protected profitability.
  3. Financial strategy emphasizes disciplined prudence with a strong, virtually debt-free balance sheet.
  4. Committed to integrating sustainable practices, including recycled aluminium and solar power.
  5. The company is no longer at the mercy of a single tide, navigating multiple currents.

Signs of Skepticism

  1. Steel sector CapEx cycles have slowed down, with less urgency to finish projects.
  2. Steel price drop is delaying orders for Sarthak Metals' products.
  3. Core cored wire business volumes declined due to monsoon and intensified competition.
  4. Initial EBITDA margins for the welding business are currently low.
  5. Management stated it's difficult to calibrate FY28 foresight for biotech.

Risk Factors

  1. Indian steel industry faces immense pressure from low-cost imports.
  2. Global steel prices, especially from Asia, are near a 5-year low.
  3. Domestic manufacturers' margins are squeezed, impacting future CapEx.
  4. Core cored wire business Q2 volumes declined 14% year-on-year.
  5. Persistent unethical competition affects the core business profitability.

Good To Know

  1. The company uses recycled aluminium scrap and operates a 400 kilowatt solar power plant.
  2. Regulations like EU's carbon border adjustment mechanism are imminent realities.
  3. The Indian steel industry must adapt and go green.
  4. Welding division's dealer network has grown to over 10 dealers across five states.
  5. Biotech market opportunity is valued at approximately ₹1.00 per liter of ethanol produced.

Key Drivers

  1. Welding division shows strong growth.
  2. Biotechnology foray offers huge market.
  3. BIS, RDSO approvals boost welding.
  4. Government biofuel push creates opportunity.

Key Analyst Discussions

Competitive Environment

  1. Intense competition and 'bad practices' are affecting the cored wire business.
  2. Company's strategy is ethical execution and service-oriented approach to regain trust.
  3. Management believes customers return to stable players once educated about industry practices.

Market Trends & Consumer Behavior

  1. Low global steel prices are subduing demand for steel and related products.
  2. Robust demand from fabrication and construction industries fills welding order books.
  3. Government's biofuel blending program creates a massive market opportunity for biotech.

Financial Highlights

  1. Steel sector CapEx has slowed, impacting demand for Sarthak Metals' products.
  2. Welding business aims for ₹25 crore sales revenue in two years.
  3. Welding EBITDA margins are currently low but expected to reach 9-10% at ₹25 crore sales.
  4. Biotech division is expected to contribute healthy double-digit margins.
  5. Overall EBITDA contribution from new businesses could be 10-15% by FY28.

Product Composition

  1. Welding business currently sells approximately 5 SKUs.
  2. Plans are in place to increase welding SKUs to 10 in the next 12-24 months.

Strategic Considerations

  1. Biotech revenue is expected to start very soon, following lucrative distillery meetings.
  2. Sarthak is actively seeking external partnerships with established players in biotech.
  3. The company is not currently focused on government grants or incentives for biotech.